Idera Pharmaceuticals, Inc.
13 clinical trials · Sponsor
◉ Watch Idera Pharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| Study of Tilsotolimod in Combination With Nivolumab and Ipilimumab for the Treatment of Solid Tumors (ILLUMINATE-206) (NCT03865082) | Idera Pharmaceuticals, Inc. | 2019-10-29 |
| A Study of Tilsotolimod in Combo With Ipilimumab vs Ipilimumab Alone in Subjects With Anti-PD-1 Refractory Melanoma (NCT03445533) | Idera Pharmaceuticals, Inc. | 2018-05-30 |
Track Idera Pharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.